Mycobacterium tuberculosis DNA in living donor transplanted livers and donor-related tuberculosis in recipients: A retrospective longitudinal cohort study

被引:3
作者
Alrajhi, Abdulrahman A. [1 ]
Alotaibi, Jawaher [1 ]
Alghamdi, Ali M. [1 ]
Almanea, Hadeel [2 ]
AlSebayel, Mohammed [3 ]
Al-Meshari, Khalid [4 ]
Al-Hajoj, Sahal [5 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Med, MBC 46,POB 3354, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Liver & Small Bowel Transplantat & Hepatopan, Riyadh, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Dept Kidney & Pancreas Transplantat, Riyadh, Saudi Arabia
[5] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Infect & Immun, Riyadh, Saudi Arabia
关键词
latent tuberculosis infection; living donor; molecular diagnostics; Mycobacterium tuberculosis; prevention; transplantation; QUANTIFERON-TB GOLD; LATENT TUBERCULOSIS; SKIN-TEST; INFECTION; POPULATION; AMPLIFICATION; DIAGNOSIS; RISK; PCR;
D O I
10.1111/tid.13212
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives Mycobacterium tuberculosis DNA has been detected in multiple organs in people without active tuberculosis or a history of tuberculosis. Molecular testing for metabolic activity has suggested that M tuberculosis DNA represents viable bacilli. Whether transplanted organs with M tuberculosis DNA can result in tuberculosis in recipients has not been assessed. Methods Biopsies obtained at the time of living donor liver transplantation were tested for the presence of M tuberculosis DNA using in situ PCR. The cohort of recipients was longitudinally followed for the development of tuberculosis. Results Living donor liver transplantation was performed for 270 patients. Mean age was 33 years (median: 41 years, range: 1-80 years). Recipients were followed for a mean of 68 months (median: 72 months, range: 1-138 months) after transplantation. Mycobacterium tuberculosis DNA was detected in 25 of 155 donated livers (16%) with liver biopsies available for testing. None of the recipients of these livers received tuberculosis chemoprophylaxis and only one (4%) developed tuberculosis 15 months after transplantation. Among the entire cohort of 270 patients, post-transplant tuberculosis was diagnosed in four patients (1.48%) at an incidence rate of 2.61 cases per 1000 transplant-years. No factors associated with developing tuberculosis were identified, including positive M tuberculosis DNA in transplanted livers. Conclusions Mycobacterium tuberculosis DNA in living donor transplanted livers did not result in tuberculosis despite post-transplant immunosuppression.
引用
收藏
页数:5
相关论文
共 26 条
[1]  
Abad CLR, 2000, CLIN TRANSPLANT, V2018
[2]   Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology [J].
Aguado, Jose Maria ;
Torre-Cisneros, Julian ;
Fortun, Jesus ;
Benito, Natividad ;
Meije, Yolanda ;
Doblas, Antonio ;
Munoz, Patricia .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (09) :1276-1284
[3]   Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis [J].
Al-Mukhaini, Suad Mohamed ;
Al-Eid, Hassan ;
Alduraibi, Fatima ;
Hakami, Hanan Ibrahim ;
Al Talhi, Haifa ;
Shoukri, Mohamed ;
Ahmed, Ahmed M. ;
Ahmed, Yusuf ;
Alrajhi, Abdulrahman A. .
ANNALS OF SAUDI MEDICINE, 2017, 37 (02) :138-143
[4]   Protocols for the in situ PCR-amplification and detection of mRNA and DNA sequences [J].
Bagasra, Omar .
NATURE PROTOCOLS, 2007, 2 (11) :2782-2795
[5]   Prevalence of Latent Mycobacterium Tuberculosis Infection (LTBI) in Saudi Arabia; Population based survey [J].
Balkhy, Hanan H. ;
El Beltagy, Kamel ;
El-Saed, Aiman ;
Aljasir, Badr ;
Althaqafi, Abdulhakeem ;
Alothman, Adel F. ;
Alshalaan, Mohammad ;
Al-Jahdali, Hamdan .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 60 :11-16
[6]   Extrapulmonary Locations of Mycobacterium tuberculosis DNA During Latent Infection [J].
Barrios-Payan, Jorge ;
Saqui-Salces, Milena ;
Jeyanathan, Mangalakumari ;
Alcantara-Vazquez, Avissai ;
Castanon-Arreola, Mauricio ;
Rook, Graham ;
Hernandez-Pando, Rogelio .
JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (08) :1194-1205
[7]   Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study [J].
Benito, N. ;
Garcia-Vazquez, E. ;
Horcajada, J. P. ;
Gonzalez, J. ;
Oppenheimer, F. ;
Cofan, F. ;
Ricart, M. J. ;
Rimola, A. ;
Navasa, M. ;
Rovira, M. ;
Roig, E. ;
Perez-Villa, F. ;
Cervera, C. ;
Moreno, A. .
CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (07) :651-658
[8]   The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement [J].
Bumbacea, Dragos ;
Arend, Sandra M. ;
Eyuboglu, Fusun ;
Fishman, Jay A. ;
Goletti, Delia ;
Ison, Michael G. ;
Jones, Christine E. ;
Kampmann, Beate ;
Kotton, Camille N. ;
Lange, Christoph ;
Ljungman, Per ;
Milburn, Heather ;
Morris, Michele I. ;
Muller, Elmi ;
Munoz, Patricia ;
Nellore, Anoma ;
Rieder, Hans L. ;
Sester, Urban ;
Theodoropoulos, Nicole ;
Wagner, Dirk ;
Sester, Martina .
EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (04) :990-1013
[9]   Comparison of the 2-Step Tuberculin Skin Test and the QuantiFERON-TB Gold In-Tube Test for the Screening of Tuberculosis Infection Before Liver Transplantation [J].
Casas, Susana ;
Munoz, Laura ;
Moure, Raquel ;
Castellote, Jose ;
Guerra, Maria R. ;
Gonzalez, Lucia ;
Andreu, Ana ;
Rafecas, Antoni G. ;
Alcaide, Fernando ;
Santin, Miguel .
LIVER TRANSPLANTATION, 2011, 17 (10) :1205-1211
[10]  
Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P333